肾小球巨噬细胞浸润强度预测IgA肾病免疫抑制治疗反应
本研究为前瞻性队列研究,纳入621例高危进展且持续蛋白尿≥1 g/d的中国IgA肾病患者,均接受免疫抑制治疗。通过免疫组化与数字图像分析量化肾活检标本中巨噬细胞浸润,发现肾小球CD206+和CD68+巨噬细胞浸润强度可预测免疫抑制治疗反应,联合MEST-C评分和临床数据后预测效能提升。
要点
- 肾小球CD206+巨噬细胞高浸润者免疫抑制治疗反应概率增加40倍。
- 肾小球CD68+巨噬细胞高浸润者治疗反应概率增加13倍。
- 联合浸润评分、MEST-C评分和临床数据可提高预测效能(AUC 0.87)。
核心结论
- 肾小球巨噬细胞浸润强度可预测高危进展IgA肾病患者对免疫抑制治疗的反应,有助于识别获益患者。
研究设计与样本
- 前瞻性队列研究,纳入621例中国IgA肾病患者,高危进展且持续蛋白尿≥1 g/d,接受优化支持治疗3个月后仍持续,均接受免疫抑制治疗中位18个月。
主要发现
- IgA肾病患者肾脏CD68+和CD206+巨噬细胞浸润增加。
- 调整分析中,肾小球CD206+巨噬细胞浸润较高者免疫抑制治疗反应概率增加40倍。
- 肾小球CD68+浸润强度较高者治疗反应概率增加13倍。
- 肾小球CD206+和CD68+巨噬细胞浸润强度预测免疫抑制治疗反应的AUC为0.84(95% CI 0.81-0.88)。
- 联合CD206+和CD68+浸润评分、MEST-C评分及活检时临床数据的模型AUC提高至0.87(95% CI 0.84-0.91)。
临床怎么用
- 肾活检时评估肾小球CD206+和CD68+巨噬细胞浸润强度,可辅助筛选可能从免疫抑制治疗中获益的高危IgA肾病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The lack of a tool for predicting the response to immunosuppressive therapy in IgA nephropathy (IgAN) limits patient-specific risk stratification and early treatment decision making. Models for predicting response to immunosuppression in IgAN that can be applied at the time of kidney biopsy are needed. METHODS: This prospective cohort study involved 621 Chinese patients with IgAN who were at high risk for disease progression and had persistent proteinuria ≥1 g/d, despite 3 months of optimized supportive care with renin-angiotensin system inhibitors. Participants received immunosuppressive therapy for a median of 18 months. We used immunochemistry to identify macrophage and lymphocyte infiltrates in biopsy specimens and digital image analysis to quantify them. The outcome was response to immunosuppression, defined as complete or partial remission within 12 months of immunosuppression. RESULTS: Kidney infiltration of CD68 + and CD206 + macrophages increased in patients with IgAN. Having higher levels of glomerular CD206 + macrophage infiltration was associated with a 40-fold increased probability of response to immunosuppression in adjusted analysis compared with having lower levels. Patients with a higher intensity of glomerular CD68 + infiltrates had a 13-fold increase in probability of responding to immunosuppression. Intensity of glomerular CD206 + and CD68 + macrophage infiltration predicted the response to immunosuppression (area under the curve [AUC], 0.84; 95% CI, 0.81 to 0.88). The AUC increased to 0.87 (95% CI, 0.84 to 0.91) in a model combining the infiltration score of CD206 + and CD68 + infiltrates with the MEST-C score and clinical data at biopsy. CONCLUSIONS: Intensity of glomerular macrophage infiltration predicted response to immunosuppressive therapy in patients with IgAN who were at high risk of progression, and may help physicians identify patients who will benefit from such treatment.
引用
- Xie D, Zhao H, Xu X, et al. Intensity of Macrophage Infiltration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IgA Nephropathy. J Am Soc Nephrol. 2021. PMID: 34670812. doi:10.1681/ASN.2021060815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。